Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Shares Issued
Ratios

Atea Pharmaceuticals (AVIR) Other Gross PP&E Adjustments (2020 - 2022)

Atea Pharmaceuticals has reported Other Gross PP&E Adjustments over the past 3 years, most recently at -$2.5 million for Q3 2022.

  • Quarterly results put Other Gross PP&E Adjustments at -$2.5 million for Q3 2022, down 1012.78% from a year ago — trailing twelve months through Sep 2022 was -$2.5 million (down 1012.78% YoY), and the annual figure for FY2021 was -$5.6 million, down 530.04%.
  • Other Gross PP&E Adjustments for Q3 2022 was -$2.5 million at Atea Pharmaceuticals, up from -$2.7 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for AVIR hit a ceiling of $175000.0 in Q3 2020 and a floor of -$5.6 million in Q4 2021.
  • Median Other Gross PP&E Adjustments over the past 3 years was -$892000.0 (2020), compared with a mean of -$1.7 million.
  • Biggest five-year swings in Other Gross PP&E Adjustments: crashed 229.71% in 2021 and later plummeted 1012.78% in 2022.
  • Atea Pharmaceuticals' Other Gross PP&E Adjustments stood at -$892000.0 in 2020, then crashed by 530.04% to -$5.6 million in 2021, then soared by 55.05% to -$2.5 million in 2022.
  • The last three reported values for Other Gross PP&E Adjustments were -$2.5 million (Q3 2022), -$2.7 million (Q2 2022), and -$2.9 million (Q1 2022) per Business Quant data.